Five MIT faculty members take on Cancer Grand Challenges
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
Scientists develop a rapid gene-editing screen to find effects of cancer mutations
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.
MIT scientists use a new type of nanoparticle to make vaccines more powerful
Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at a lower dose.
How early-stage cancer cells hide from the immune system
A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.
2023-25 MIT Postdoctoral Fellowship Program for Engineering Excellence cohort announced
Thirteen postdocs join program that emphasizes community and prioritizes professional development.
What can super-healing species teach us about regeneration?
Albert Almada PhD ’13 studies the mechanics of how stem cells rebuild tissues. “Digging deep into the science is what MIT taught me,” he says.
Hitchhiking cancer vaccine makes progress in the clinic
MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.
Robert Langer receives Dr. Paul Janssen Award
Award honors “scientists who have made a transformational contribution toward the improvement of human health.”
MIT community members honored with 2024 Franklin Institute Awards
Two professors and three additional alumni recognized for “dreaming up solutions to global challenges — advancing health, sustainability, and human connection.”
Nancy Hopkins awarded the National Academy of Sciences Public Welfare Medal
The MIT professor emerita and pioneering molecular biologist is being honored for her advocacy for women in science.
MIT Faculty Founder Initiative announces finalists for second competition
Twelve researchers selected as finalists for 2023-24 MIT-Royalty Pharma Prize Competition to support female entrepreneurs in biotech.
Researchers improve blood tests’ ability to detect and monitor cancer
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
Inhalable sensors could enable early lung cancer detection
The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.
MIT community members elected to the National Academy of Inventors for 2023
MIT Koch Institute researchers Daniel Anderson and Ana Jaklenec, plus 11 MIT alumni, are honored for inventions that have made a tangible impact on society.
MIT’s tiny technologies go to Washington
Cancer nanomedicine was on display at the 2023 White House Demo Day.